NeuroDigm Co. LLC

NeuroDigm’s mission is to help translate clinical knowledge into a new platform to help basic science and technology conquer chronic pain. With methods based on clinical insights NeuroDigm can offer a unique perspective in the development of products to develop treatments for neuropathic chronic pain conditions.

Our goal to embody a new theoretical model for neural pain into an animal model has been realized. The NeuroDigm™ GEL Model represents the majority of human neural pain conditions without evidence of nerve damage by clinical testing. We can help you develop new treatments for this large inadequately served group, which comprises the majority of neuropathic pain patients.

The NeuroDigm™ GEL Model represents the persistent pain syndromes gradually occurring after musculoskeletal strains, soft tissue injuries, industrial overuse conditions, surgeries, “pinched” nerves, minor or major trauma and fascial nerve entrapments. A chronically inflamed “pinched nerve” can create more pain than a damaged dying nerve, due to the stimulus for regeneration. This patented process can also be used to represent causes of Low Back Pain and Sciatica.

NeuroDigm’s models will transform your research on the diagnosis and treatment of many persistent neural pain syndromes. Your screening and discovery may have new answers, even on prior agents. This model can help the development of effective biologics for neuropathic pain.

NeuroDigm™ GEL Model is a research tool. The FDA Safe Harbor Act for drug development does not apply to a research tool.